A positive surprise is on the way: Bionomics Ltd. ADR (BNOX) Stock

H.C. Wainwright raised the price target for the Bionomics Ltd. ADR (NASDAQ:BNOX) stock from “a Neutral” to “a Buy”. The rating was released on September 28, 2023, according to finviz. We previously noted in another research note published on September 28, 2023 by Maxim Group that reiterated the stock to a Buy with a price target of $10 for BNOX stock. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $54. The stock was initiated by Evercore ISI, who disclosed in a research note on January 10, 2022, to Outperform and set the price objective to $17. In their research brief published January 10, 2022, Cantor Fitzgerald analysts initiated the Bionomics Ltd. ADR stock to Overweight with a price target of $52.

Historical Earnings Surprises and Revenue Forecasts

It appears that the average earnings per share estimate for the current quarter (ending in Mar 2022) is $0. This is an average of 0 analysts’ earnings, where the high earnings per share estimate is $0 and the low earnings per share estimate is $0.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The latest trade, Performances and Moving Averages give us the following Picture

The firm’s stock price fluctuated 3.00% within the last five trades and -17.27% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 4.57% in the last 6 months and -27.46% was subtracted to its value over the previous 3 months. BNOX stock is trading at a margin of -5.49%, -3.87% and -43.04% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

As of the close of trading, BNOX deals in the Healthcare domain. The stock is trading -83.93 percent below its 52-week high and 18.39 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -74.94. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does Bionomics Ltd. ADR’s Profitability and Valuation Ratios Tell Us About the Stock?

With regard to the profitability of the company, the operating margin is currently at -137808.26 percent and the profit margin is -138260.67 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.

The stock’s market cap achieved a total value of $11.01 million as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 1101.07 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 0.56, which equates the market value of a stock with its book value.

Most Popular

Related Posts